Potential Shift of KRASG12C Inhibitors to the Front-line Setting

Video

Two experts discuss the potential role of using adagrasib and sotorasib in the front-line setting and how it might shift the treatment paradigm for patients with KRASG12C-mutated NSCLC with CNS metastases.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos